Evidence map›Paper›PMID 32311029›Full record

ArticleThe Journal of infectious diseases2020

Newborns With Zika Virus-Associated Microcephaly Exhibit Marked Systemic Inflammatory Imbalance.

Caian L Vinhaes, María B Arriaga, Breno L de Almeida, João V Oliveira, Cleiton S Santos, Juan I Calcagno, Tereza X Carvalho, Marta Giovanetti, Luiz Carlos J Alcantara, Isadora C de Siqueira and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Compartment-specific inflammation in tuberculous lymphadenitis: a case-control study.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Offspring affected withEmerging microbes & infections · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Drugs to limit Zika virus infection and implication for maternal-fetal health.Frontiers in virology (Lausanne, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Caian L VinhaesInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
María B ArriagaInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Breno L de AlmeidaInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
João V OliveiraInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Cleiton S SantosInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Juan I CalcagnoMaternidade de Referência Prof. José Maria de Magalhães Netto-Secretaria de Saúde do Estado da Bahia (SESAB), Salvador, Brazil.
Tereza X CarvalhoMaternidade de Referência Prof. José Maria de Magalhães Netto-Secretaria de Saúde do Estado da Bahia (SESAB), Salvador, Brazil.
Marta GiovanettiLaboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Luiz Carlos J AlcantaraLaboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Isadora C de SiqueiraInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Bruno B AndradeInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Fundação Oswaldo Cruz · BRSecretaria da Saúde · BRUniversidade Federal da Bahia · BRUniversidade Federal de Minas Gerais · BRFaculdade de Tecnologia e Ciências · BR

Funding

Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
NIAID NIH HHS U01 AI115940
6 · The paper itself

Abstract

backgroundZika virus (ZIKV) is an emergent flavivirus initially considered a benign and self-limited exanthematic illness. In 2015, a new epidemic emerged in northeastern of Brazil with increased incidence of a previously rare clinical outcome, microcephaly, in newborns from mothers who were infected during pregnancy. Little is known about the immunopathogenesis of ZIKV-associated microcephaly. Understanding the inflammatory profile and degree of inflammation of persons affected with such condition is an important step towards development of innovative therapeutic strategies.

methodsA case-control study compared plasma levels of several inflammatory biomarkers from newborns with ZIKV microcephaly, asymptomatic ZKV infection, or uninfected controls. Plasma biomarkers were assessed using Luminex. A series of multidimensional analysis was performed to characterize the systemic immune activation profile of the clinical groups.

resultsWe identified an inflammatory signature associated with ZIKV microcephaly that suggested an increased inflammation. Network analysis suggested that ZIKV microcephaly is associated with imbalanced immune activation and inflammation. The cephalic perimeter was inversely proportional with the degree of inflammatory perturbation. Furthermore, a combination of plasma inflammatory biomarkers could discriminate ZIKV with microcephaly from those with ZIKV without microcephaly or uninfected neonates.

conclusionsAn intense inflammatory imbalance that is proportional to the disease severity hallmarks ZIKV microcephaly.

Indexed as

BiomarkersBrazilCase-Control StudiesFemaleHumansInfant, NewbornInflammationMaleMicrocephalyZika VirusZika Virus InfectionBiomarkersinflammationmicrocephalynewbornsZika virus

Identifiers

PMID32311029
PMCPMC7377289
OpenAlexW3016932006

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.